Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions

Biochimie

Volumn 88, Issue 5, 2006, Pages 515-525

  Barreau, Carine ^a   Paillard, Luc ^a   Méreau, Agnès ^a   Osborne, H Beverley ^a  

^a CNRS   (France)

Author keywords

Alternative splicing; mRNA stability; Translation

Indexed keywords

BRUNOL PROTEIN; CELF PROTEIN; DROSOPHILA PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

BIOLOGICAL MODEL; MAMMAL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL CYCLE; GENE EXPRESSION PROFILING; HUMANS; MODELS, BIOLOGICAL; RNA-BINDING PROTEINS;

MAMMALIA;

EID: 33744980908     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.10.011     Document Type: Review

References (61)

1. Timchenko L.T., Miller J.W., Timchenko N.A., DeVore D.R., Datar K.V., Lin L., Roberts R., Caskey C.T., and Swanson M.S. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24 (1996) 4407-4414
2. Hwang D.M., Hwang W.S., and Liew C.C. Single pass sequencing of a unidirectional human fetal heart cDNA library to discover novel genes of the cardiovascular system. J. Mol. Cell. Cardiol. 26 (1994) 1329-1333
3. Kim-Ha J., Kerr K., and Macdonald P.M. Translational regulation of oskar mRNA by Bruno, an ovarian RNA-binding protein is essential. Cell 81 (1995) 403-412
4. Cummings C.J., and Zoghbi H.Y. Trinucleotide repeats: mechanisms and pathophysiology. Annu. Rev. Genomics Hum. Genet. 1 (2000) 281-328
5. Choi D.K., Ito T., Mitsui Y., and Sakaki Y. Fluorescent differential display analysis of gene expression in apoptotic neuroblastoma cells. Gene 223 (1998) 21-31
6. Lu X., Timchenko N.A., and Timchenko L.T. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8 (1999) 53-60
7. Good P., Chen O., Warner S., and Herring D. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem. 275 (2000) 28583-28592
8. Ladd A.N., Charlet-B N., and Cooper T. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21 (2001) 1285-1296
9. Li D., Bachinski L.L., and Roberts R. Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. Genomics 74 (2001) 396-401
10. Ladd A.N., Nguyen N.H., Malhotra K., and Cooper T.A. CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem. 279 (2004) 17756-17764
11. Roberts R., Timchenko N., Miller J., Reddy S., Caskey C., Swanson M., and Timchenko L. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94 (1997) 13221-13226
12. Ladd A.N., and Cooper T.A. Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events. J. Cell Sci. 117 (2004) 3519-3529
13. Cooper T.A., and Ordahl C.P. A single troponin T gene regulated by different programs in cardiac and skeletal muscle development. Science 226 (1984) 979-982
14. Cooper T.A., and Ordahl C.P. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J. Biol. Chem. 260 (1985) 11140-11148
15. Cooper T.A. Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol. Cell. Biol. 18 (1998) 4519-4525
16. Philips A.V., Timchenko L.T., and Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280 (1998) 737-741 [see comments]
17. Ryan K.J., and Cooper T.A. Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol. Cell. Biol. 16 (1996) 4014-4023
18. Faustino N.A., and Cooper T.A. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol. 25 (2005) 879-887
19. Charlet B.N., Logan P., Singh G., and Cooper T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9 (2002) 649-658
20. Han J., and Cooper T.A. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res. 33 (2005) 2769-2780
21. Ladd A.N., Stenberg M.G., Swanson M.S., and Cooper T.A. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 233 (2005) 783-793
22. Ho T.H., Bundman D., Armstrong D.L., and Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 14 (2005) 1539-1547
23. Savkur R.S., Philips A.V., and Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29 (2001) 40-47
24. Zhang W., Liu H., Han K., and Grabowski P.J. Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR. RNA 8 (2002) 671-685
25. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., and Thornton C.A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10 (2002) 35-44
26. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., and Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10 (2002) 45-53
27. Poleev A., Hartmann A., and Stamm S. A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene. Eur. J. Biochem. 267 (2000) 4002-4010
28. Descombes P., and Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67 (1991) 569-579
29. Stein G.H., Drullinger L.F., Soulard A., and Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19 (1999) 2109-2117
30. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
31. Timchenko N.A., Welm A.L., Lu X., and Timchenko L.T. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 27 (1999) 4517-4525
32. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., and Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol. 21 (2001) 6927-6938
33. Welm A.L., Mackey S.L., Timchenko L.T., Darlington G.J., and Timchenko N.A. Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA. J. Biol. Chem. 275 (2000) 27406-27413
34. Baldwin B.R., Timchenko N.A., and Zahnow C.A. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol. Cell. Biol. 24 (2004) 3682-3691
35. Iakova P., Wang G.L., Timchenko L., Michalak M., Pereira-Smith O.M., Smith J.R., and Timchenko N.A. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate. EMBO J. 23 (2004) 406-417
36. Timchenko L.T., Iakova P., Welm A.L., Cai Z.J., and Timchenko N.A. Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins. Mol. Cell. Biol. 22 (2002) 7242-7257
37. Timchenko N.A., Wang G.L., and Timchenko L.T. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J. Biol. Chem. 280 (2005) 20549-20557
38. Calkhoven C.F., Muller C., and Leutz A. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev. 14 (2000) 1920-1932
39. Paillard L., and Osborne H.B. East of EDEN was a poly(A) tail. Biol. Cell. 95 (2003) 211-219
40. Paillard L., Omilli F., Legagneux V., Bassez T., Maniey D., and Osborne H.B. EDEN and EDEN-BP, a cis element and an associated factor that mediates sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J. 17 (1998) 278-287
41. Ezzeddine N., Paillard L., Capri M., Maniey D., Bassez T., Aït-Ahmed O., and Osborne B. EDEN dependent translational repression of maternal mRNAs is conserved between Xenopus and Drosophila. Proc. Natl. Acad. Sci. USA 99 (2002) 257-262
42. Paillard L., Legagneux V., and Beverley Osborne H. A functional deadenylation assay identifies human CUG-BP as a deadenylation factor. Biol. Cell. 95 (2003) 107-113
43. Detivaud L., Pascreau G., Karaiskou A., Osborne H., and Kubiak J. Regulation of EDEN-dependent deadenylation of Aurora A/Eg2 derived mRNA via phosphorylation and dephosphorylation in Xenopus laevis egg extracts. J. Cell Sci. 116 (2003) 2697-2705
44. Gautier-Courteille C., Le Clainche C., Barreau C., Audic Y., Graindorge A., Maniey D., Osborne H.B., and Paillard L. EDEN-BP-dependent post-transcriptional regulation of gene expression in Xenopus somitic segmentation. Development 131 (2004) 6107-6117
45. Paillard L., Legagneux V., Maniey D., and Osborne H. c-jun ARE targets mRNA deadenylation by an EDEN-BP (embryo deadenylation element binding protein) dependent pathway. J. Biol. Chem. 277 (2002) 3232-3235
46. Chen C.-Y.A., and Shyu A.-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
47. Mukhopadhyay D., Houchen C.W., Kennedy S., Dieckgraefe B.K., and Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11 (2003) 113-126
48. Richter J.D., and Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433 (2005) 477-480
49. Ryseck R.P., Hirai S.I., Yaniv M., and Bravo R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature 334 (1988) 535-537
50. Berry L.D., and Gould K.L. Regulation of Cdc2 activity by phosphorylation at T14/Y15. Prog. Cell Cycle Res. 2 (1996) 99-105
51. Wilkinson M.F., and Shyu A.B. Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm. Bioessays 23 (2001) 775-787
52. Bonnet-Corven S., Audic Y., Omilli F., and Osborne H.B. An analysis of the sequence requirements of EDEN-BP for specific RNA binding. Nucleic Acids Res. 30 (2002) 4667-4674
53. Singh G., Charlet B.N., Han J., and Cooper T.A. ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo. Nucleic Acids Res. 32 (2004) 1232-1241
54. Choi D.K., Ito T., Tsukahara F., Hirai M., and Sakaki Y. Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein. Gene 237 (1999) 135-142
55. Knecht A.K., Good P.J., Dawid I.B., and Harland R.M. Dorsal-ventral patterning and differentiation of noggin-induced neural tissue in the absence of mesoderm. Development 121 (1995) 1927-1936
56. Richter K., Grunz H., and Dawid I.B. Gene expression in the embryonic nervous system of Xenopus laevis. Proc. Natl. Acad. Sci. USA 85 (1988) 8086-8090
57. Suzuki H., Maegawa S., Nishibu T., Sugiyama T., Yasuda K., and Inoue K. Vegetal localization of the maternal mRNA encoding an EDEN-BP/Bruno-like protein in zebrafish. Mech. Dev. 93 (2000) 205-209
58. Suzuki H., Jin Y., Otani H., Yasuda K., and Inoue K. Regulation of alternative splicing of alpha-actinin transcript by Bruno-like proteins. Genes Cells 7 (2002) 133-141
59. Ladd A.N., Taffet G., Hartley C., Kearney D.L., and Cooper T.A. Cardiac tissue-specific repression of CELF activity disrupts alternative splicing and causes cardiomyopathy. Mol. Cell. Biol. 25 (2005) 6267-6278
60. Gromak N., Matlin A.J., Cooper T.A., and Smith C.W. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA 9 (2003) 443-456
61. Wollerton M.C., Gooding C., Wagner E.J., Garcia-Blanco M.A., and Smith C.W. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13 (2004) 91-100